Results 121 to 130 of about 5,540,950 (140)

Teprotumumab for Thyroid Eye Disease

International Ophthalmology Clinics, 2020
Christopher J, Hwang, Kian, Eftekhari
openaire   +2 more sources

Management of Thyroid Eye Disease: A Consensus Statement by the American Thyroid Association and the European Thyroid Association

Thyroid, 2022
Petros Perros, Angela M Leung, Mario Salvi   +2 more
exaly  

Glucocorticoids for Thyroid Eye Disease

International Ophthalmology Clinics, 2021
Peter J, Dolman, Magdalena A, Wirth
openaire   +2 more sources

A Survey on the Management of Thyroid Eye Disease Among American and European Thyroid Association Members

Thyroid, 2022
Miloš Zarkovic, Endre Nagy, László Hegedus   +2 more
exaly  

Medical Therapy in Patients with Moderate to Severe, Steroid-Resistant, Thyroid Eye Disease

Thyroid, 2023
Andrea Tooley, Marius Stan, David Toro-Tobón   +2 more
exaly  

2022 Update on Clinical Management of Graves Disease and Thyroid Eye Disease

Endocrinology and Metabolism Clinics of North America, 2022
Thanh Hoang, Henry Burch
exaly  

The Role of Thyroid Antibodies in Thyroid Eye Disease

International Ophthalmology Clinics, 2023
Rachel Shemesh, Guy J. Ben Simon, Ofira Zloto   +2 more
openaire   +2 more sources

Teprotumumab for the Treatment of Active Thyroid Eye Disease

New England Journal of Medicine, 2020
Claudio Marcocci, Robert Holt, Mario Salvi   +2 more
exaly  

Teprotumumab for chronic thyroid eye disease

Orbit, 2022
Liane Dallalzadeh, Daniel J Ozzello
exaly  

Risk Factors of Thyroid Eye Disease

Endocrine Practice, 2021
Chin Meng Khoo, Gangadhara Sundar, Cheng Han Ng   +2 more
exaly